Agenus
Open
$3.93
Prev. Close
$3.93
High
$3.94
Low
$3.90
Market Snapshot
$130.59M
-1293.0
-10.58
$103.46M
316
The company is headquartered in Lexington, Massachusetts. The company went IPO on 2000-02-04.
emptyResult
The company is headquartered in Lexington, Massachusetts. The company went IPO on 2000-02-04.
Recently from Cashu
Agenus Drives Immuno-Oncology Advancements Amid Biopharmaceutical Landscape Changes
Agenus Responds to Emerging Trends in the Biopharmaceutical Landscape Agenus continues to position itself at the forefront of immuno-oncology, driven by innovative therapies aimed at improving treatme…
Agenus Partners with Zydus Lifesciences to Enhance Biologics Manufacturing Capabilities
Agenus Partners with Zydus Lifesciences to Strengthen Biologics Manufacturing Capabilities Agenus Inc. solidifies its strategic positioning in the biopharmaceutical sector through a significant partne…
Agenus: Leading Innovation in Immuno-Oncology Amidst Market Dynamics
Agenus: Pioneering Immuno-Oncology Developments Amid Market Dynamics Agenus, a leading biotechnology company focused on immuno-oncology, continues to make significant strides in its research and devel…
Agenus Advances Immunotherapy with New Trials for AGEN1181 and Cancer Treatment Strategies
Agenus Advances Immunotherapy Pipeline with New Clinical Trial Initiatives Agenus, a biotechnology firm specializing in immunotherapy, announces significant developments in its clinical pipeline, part…